Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.


Overview | Financials
Company Name Evelo Biosciences, Inc.
Symbol EVLO
Currency USD
Price 0.06
Market Cap 1,138,968
Dividend Yield 0%
52-week-range 0.001 - 13.93
Industry Biotechnology
Sector Healthcare
CEO Dr. Balkrishan Gill Ph.D.
Website https://www.evelobio.com

An error occurred while fetching data.

About Evelo Biosciences, Inc.

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as

Related Stocks

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.


2.56 USD

NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.


2.65 USD

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.


0.435 USD

Passage Bio, Inc. logo

Passage Bio, Inc.


0.91 USD


Numbers are in millions USD

Numbers are in millions USD